Quality of care indicators for the care of human immunodeficiency virus-infected individuals, adapted to the pediatric age

被引:1
|
作者
Soler-Palacin, Pere [1 ]
Clara Provens, Ana [1 ]
Martin-Nalda, Andrea [1 ]
Espiau, Maria [1 ]
Fernandez-Polo, Aurora [2 ]
Figueras, Concepcio [1 ]
机构
[1] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Unitat Patol Infecciosa & Immunodeficiencies Pedi, E-08193 Barcelona, Spain
[2] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Serv Farm, E-08193 Barcelona, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2014年 / 32卷 / 03期
关键词
Human immunodeficiency virus; Pediatrics; Health care quality indicators; COMBINATION ANTIRETROVIRAL THERAPY; PROTEASE INHIBITOR; RENAL-FUNCTION; HEPATITIS-A; HIV; CHILDREN; COHORT; LIVER; RISK;
D O I
10.1016/j.eimc.2013.02.010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Since infection with human immunodeficiency virus (HIV) was first described, there have been many advances in its diagnosis, monitoring and treatment. However, few contributions are related to the area of health care quality. In this sense, the Spanish Study Group on AIDS (GESIDA) has developed a set of quality care indicators for adult patients living with HIV infection that includes a total of 66 indicators, 22 of which are considered to be relevant. Standards were calculated for each of them in order to reflect the level of the quality of care offered to these patients. Similar documents for pediatric patients are currently lacking. Methods: Preparation of a set of quality care indicators applicable to pediatric patients based on the GESIDA document and the Spanish Guidelines for monitoring of pediatric patients infected with HIV. Each indicator was analysed with respect to the required standards in all patients under 18 years of age followed-up in our Unit, with the aim of evaluating the quality of care provided. Results: A total of 61 indicators were collected (51 from the GESIDA document and 10 from currently available pediatric guidelines), 30 of which were considered to be relevant. An overall compliance of 81%-83% was obtained when assessing the relevant indicators. Conclusion: The availability of health care quality standards is essential for the care of pediatric HIV-infected patients. The assessment of these indicators in our Unit yielded satisfactory results. (C) 2012 Elsevier Espana, S.L. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
引用
收藏
页码:160 / 169
页数:10
相关论文
共 50 条
  • [21] Critical Care of Persons Infected with the Human Immunodeficiency Virus
    Ganesan, Anuradha
    Masur, Henry
    CLINICS IN CHEST MEDICINE, 2013, 34 (02) : 307 - +
  • [22] Advanced heart failure in patients infected with human immunodeficiency virus: Is there equal access to care?
    Uriel, Nir
    Nahumi, Nadav
    Colombo, Paolo C.
    Yuzefpolskaya, Lana
    Restaino, Susan W.
    Han, Jason
    Thomas, Sunu S.
    Garan, Arthur R.
    Takayama, Hiroo
    Mancini, Donna M.
    Naka, Yoshifumi
    Jorde, Ulrich P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (09) : 924 - 930
  • [23] LONG-TERM EFFICACY AND SAFETY OF FOSAMPRENAVIR IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PEDIATRIC PATIENTS
    Palladino, Claudia
    Briz, Veronica
    Negre Policarpo, Sergio
    Fernandez Silveira, Laura
    Isabel de Jose, M.
    Isabel Gonzalez-Tome, M.
    Moreno, David
    Leon Leal, Juan A.
    Jose Mellado, M.
    de Ory, Santiago J.
    Ramos, Jose T.
    Angeles Munoz-Fernandez, M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (06) : 563 - 566
  • [24] Hyperhomocysteinemia in human immunodeficiency virus-infected patients
    Duro, M.
    Manso, M. C.
    Rebelo, I
    Medeiros, R.
    Almeida, C.
    BIOMEDICAL RESEARCH-INDIA, 2016, 27 (02): : 557 - 562
  • [25] Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patients
    King, JR
    Acosta, EP
    Chadwick, E
    Yogev, R
    Crain, M
    Pass, R
    Kimberlin, DW
    Sturdevant, MS
    Aldrovandi, GM
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (03) : 239 - 244
  • [26] Hepatitis C virus in human immunodeficiency virus-infected individuals: An emerging comorbidity with significant implications
    Gonzalez, SA
    Talal, AH
    SEMINARS IN LIVER DISEASE, 2003, 23 (02) : 149 - 166
  • [27] Electrochemical sensing method for point-of-care cortisol detection in human immunodeficiency virus-infected patients
    Kaushik, Ajeet
    Yndart, Adriana
    Jayant, Rahul Dev
    Sagar, Vidya
    Atluri, Venkata
    Bhansali, Shekhar
    Nair, Madhavan
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 : 677 - 685
  • [28] Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit
    Croda, Julio
    Croda, Mariana Garcia
    Neves, Alan
    dos Santos, Sigrid De Sousa
    CRITICAL CARE MEDICINE, 2009, 37 (05) : 1605 - 1611
  • [29] Psychosocial aspects in a cohort of vertically transmitted human immunodeficiency virus-infected adolescents
    Garcia-Navarro, Cristina
    Garcia, Isabel
    Medin, Gabriela
    Tomas Ramos-Arnador, Jose
    Navarro-Gomez, Marisa
    Jose Mellado-Pena, M.
    de Jose Gomez, M. I.
    Cortes, Marisol
    Zamora Crespo, Berta
    Angeles Munoz-Fernandez, M.
    Blazquez Gamero, Daniel
    Isabel Gonzalez-Tome, M.
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2014, 32 (10): : 631 - 637
  • [30] Surrogate Biomarkers of Disease Progression in Human Pegivirus Seropositive Human Immunodeficiency Virus-Infected Individuals
    Vimali, Jaisheela
    Yong, Yean K.
    Murugesan, Amudhan
    Ashwin, Rajeev
    Balakrishnan, Pachamuthu
    Raju, Sivadoss
    Velu, Vijayakumar
    Larsson, Marie
    Shankar, Esaki M.
    VIRAL IMMUNOLOGY, 2023, 36 (01) : 55 - 62